High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo

High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo

A retrospective chart review of 4,925 human African trypanosomiasis patients treated with melarsoprol in 2001–2003 in Equateur Nord Province of the Democratic Republic of Congo showed a treatment failure rate of 19.5%. This rate increased over the 3 years. Relapse rates were highest in the central p...

Full description

Bibliographic Details
Main Authors: Jo Robays, Gaspard Nyamowala, Claude Sese, Victor Betu Ku Mesu Kande, Pascal Lutumba, Wim Van der Veken, Marleen Boelaert
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2008-06-01
Series:Emerging Infectious Diseases
Subjects:
Human African trypanosomiasis
relapse
treatment
melarsoprol
dispatch
Congo
Online Access:https://wwwnc.cdc.gov/eid/article/14/6/07-1266_article

Internet

https://wwwnc.cdc.gov/eid/article/14/6/07-1266_article

Similar Items